Pediatric and Geriatric Pharmacology: Lifespan Drug Therapy

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/29

encourage image

There's no tags or description

Looks like no tags are added yet.

30 Terms

1
New cards

Pediatrics vs. Adults Rule

Children are not "tiny adults"; they have major differences in both pharmacokinetics and pharmacodynamics from infancy through adolescence [3].

2
New cards

BPCA (Best Pharmaceuticals for Children Act)

Federal legislation providing safety and efficacy guidelines for pediatric medications, where research is historically limited [3].

3
New cards

Pediatric Age Group: Term Neonate

Birth at 38 or more weeks of gestation up to 27 days of life [3].

4
New cards

Pediatric Age Group: Infant / Toddler

28 days of life up to 23 months of age [4].

5
New cards

Pediatric Age Group: Child

24 months (2 years) up to 11 years of age [4].

6
New cards

Pediatric Age Group: Adolescent

12 years up to 16 to 18 years of age [4].

7
New cards

Pediatric Oral Absorption

Absorption is slower and less effective in neonates and infants due to immature stomach function and a higher (less acidic) gastric pH until age 2 to 3 [5].

8
New cards

Pediatric IM & Subcutaneous Absorption

Variable and unpredictable because of immature peripheral blood flow and sensitivity to cold temperatures, dehydration, or low cardiac output [5].

9
New cards

Pediatric Topical (Skin) Absorption

Infants have thinner skin and a much higher body surface area relative to body mass, significantly increasing the risk of drug toxicity from topical medications [6].

10
New cards

Pediatric Body Water & Drug Distribution

Neonates and infants are approximately 75% water (compared to 60% in adults), meaning water-soluble medications are diluted and require higher weight-based doses until age 2 [6, 7].

11
New cards

Pediatric Protein Binding & Toxicity

Neonates have lower protein (albumin) levels and fewer binding sites, leaving more active "free drug" circulating in the bloodstream and increasing toxicity risk [7].

12
New cards

Bilirubin and Drug Binding

High bilirubin levels in neonates can displace medications from protein-binding sites, causing higher free drug concentrations [7].

13
New cards

Pediatric Blood-Brain Barrier (BBB)

The blood-brain barrier is immature in neonates and cannot effectively block medications from entering the central nervous system [7].

14
New cards

Pediatric Drug Metabolism

Highly variable by developmental maturity; children typically reach adult metabolic capacity around 11 years of age [8].

15
New cards

Pediatric Drug Excretion (GFR)

A term neonate's glomerular filtration rate (GFR) is only about 30% of an adult's, reaching adult levels by 12 months; nurses must closely monitor urine output and renal function [8].

16
New cards

Pediatric Oral Dosage Forms by Age

Infants receive small-volume liquids; young children can take liquids, effervescent tablets, or food sprinkles; children ages 6 to 11 can chew tablets; adolescents take adult forms [9, 10].

17
New cards

Pediatric Atraumatic Care & Development

Nursing interventions and medication administration should minimize physical and psychological distress, tailored using Piaget's cognitive and Erikson's psychosocial stages [10].

18
New cards

Geriatric Dosing Rule: "Start Low and Go Slow"

Older adults should start at lower doses because of altered organ function and a higher risk of adverse reactions and toxicity [11].

19
New cards

Geriatric Chronic Illness Burden

92% of older adults live with at least one chronic illness, and 75% live with at least two, complicating medication therapy [11].

20
New cards

Geriatric Gastrointestinal Absorption Changes

Older adults experience decreased small bowel surface area, reduced gastric blood flow, slowed gastric emptying, and decreased stomach acid production [12].

21
New cards

Geriatric Fat Distribution & Half-Life

A decline in muscle mass leads to a 20% to 40% increase in body fat, causing fat-soluble drugs to have a larger volume of distribution, prolonged action, and delayed elimination [12].

22
New cards

Geriatric Water Distribution Changes

Total body water decreases by 10% to 15%, reducing the volume of distribution for water-soluble medications and increasing drug concentration [13, 14].

23
New cards

Geriatric Albumin Levels & Free Drug

Serum albumin declines by approximately 10%, reducing available binding sites and increasing circulating free active drug, which heightens toxicity risk [14].

24
New cards

Geriatric Hepatic Metabolism Changes

Hepatic blood flow decreases by up to 40% and liver size shrinks by 15% to 30%, which reduces first-pass metabolism, prolongs drug half-life, and increases toxicity risk [14].

25
New cards

Geriatric Renal Clearance Decline

After age 40, GFR generally declines by 1 mL/min per year; kidney function must be tracked via GFR, creatinine clearance (ClCr), and BUN to adjust narrow therapeutic range drugs [14, 15].

26
New cards

Drug Classes Needing Renal Dose Adjustments

Beta-blockers, NSAIDs, opioids, diuretics, diabetic medications, antimicrobials (antibiotics, antifungals, antivirals), and cholesterol drugs [15].

27
New cards

Geriatric Blood-Brain Barrier & Pharmacodynamics

Receptor site density and sensitivity change (notably for CNS and cardiovascular drugs), and the blood-brain barrier becomes more permeable over time [16].

28
New cards

Polypharmacy Definition & Risks

The use of more medications than medically necessary; major risk factors include seeing multiple doctors, having multiple chronic conditions, female sex, hospitalizations, and OTC drug use [16].

29
New cards

Beers Criteria

A clinical guideline identifying potentially inappropriate medications that should generally be avoided or used with caution in older adults [16].

30
New cards

Geriatric Patient Teaching Considerations

Before providing medication education, assess sensory and physical needs such as eyeglasses, print and font size, hearing acuity, and voice tone [17].